Using neurostimulation to activate the nervous system
Thync is a bioelectronics company developing pioneering products and treatments.
Our non-invasive, bioelectronic platform effectively targets autonomic nerve pathways important in a number of disease processes and impactful for everyday living.
We are focused on commercialization of our neurostimulation patches for consumer applications.
Our first generation UseYourHead Energy Patches are truly innovative and simply a cleaner way to energize.
Our ingenious second generation FeelZing Patches help you energize and focus without jitters.
Scientific Publications
PeerJ
Nature Reports
BioRxiv
Scientific Research and Usage
Thync's core technology for non-invasively modulating the autonomic nervous system was developed by a team of neuroscientists from MIT, Harvard, & Stanford. It has been extensively tested and used in the consumer health market and subsequently enhanced to become a therapeutic platform.
We started Thync with the vision of creating the first personal technologies that would interact directly with the brain and the nervous system. After years of research, our small but powerful team of neuroscientists and engineers were first able to create a bioelectronic platform to lower stress and anxiety acutely. Thync brought this technology to the consumer health market via its wearable products, Thync Edition One and Thync Relax Pro.
With over 10,000 people using Thync products we learned that our technology was used most consistently by individuals with a high need to manage stress, anxiety, and improve their sleep. We also learned it was nearly impossible to validate the impact of our products on mental health by remaining a consumer products company.
As this was taking place, we discovered our bioelectronic platform had the potential to impact autoimmune disorders. This discovery was reinforced by increasing evidence and awareness that the nervous system plays a key role in autoimmune disorders.
So, we took advantage of our greatest strength as a start-up and rapidly pursued this direction to generate striking pilot data results in Psoriasis. By helping psoriasis patients manage their life-long condition in a drug-free manner, we can help millions of people and establish a strong foundation for bioelectronics therapies. Success will lead to treatments for tens of millions of patients that suffer from mental health, inflammatory disorders, and skin conditions.
As a bioelectronics medicine venture, we are conducting clinical studies to prove that our bioelectronic therapies are not only a new way but a better way to treat a number of chronic, autoimmune and mental disorders.
If you are interested in joining a Thync clinical study or partnering with Thync, please reach out to us by emailing contact@thync.com.
Bioelectronic therapies are being developed to effectively treat a number of disorders, that currently can only be addressed using pharmaceutical interventions.
A growing body of scientific literature demonstrates the important role the nervous system plays in regulating the body’s immune response. These findings support the use of modulating the peripheral nervous system to potentially treat chronic inflammatory conditions such as Psoriasis, Lupus, IBD, and Rheumatoid Arthritis.
Thync's bioelectronic platform targets cervical and thoracic spinal nerves to systemically modulate autonomic nervous system activity. Proprietary electrical neuromodulation programs are used to provide high efficacy without any pain or discomfort. These neural pathways are involved in a number of important disease processes including the immune response.
